Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05342129
Other study ID # 2020-07-022B
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 17, 2020
Est. completion date March 1, 2022

Study information

Verified date April 2022
Source Taipei Veterans General Hospital, Taiwan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In recent years, due to the improvement in the survival rate of the intensive care unit, the problem of severe systemic fatigue (Intensive care unit acquired weakness; ICUAW) has continued to receive attention. Muscle mass decreases by 3-11% within a week, resulting in decreased muscle strength and muscle atrophy. Current studies suggest that ICUAW can lead to poorer function, prolonged ICU stay, and decreased quality of life. This study aimed to understand the muscle strength of critically ill patients and to explore the effect of exercise intervention on improving muscle strength. The experimental group received a four-week exercise bike intervention plus conventional rehabilitation exercises, while the control group received conventional rehabilitation exercises.


Description:

The content of the exercise is to use an exercise bike, start pedaling on the first day, time setting: 20 minutes, speed: 2, and adopt passive mode. If you can complete the exercise on the first day, the time will be adjusted to 30 minutes on the second day. If you cannot complete the exercise on the first day, the time will still start from 20 minutes on the second day. The maximum time is 30 minutes. If you can complete 30 minutes of passive exercise for 3 consecutive days, the fourth day will be adjusted to active exercise. The entire exercise training is seven days a week, once a day, once a 30-minute, at least 5 days. Those who were discharged to the general ward continued to complete this exercise training for up to 28 days. Stop exercising if heartbeat > 140, mean arterial pressure < 65, blood oxygen < 90%, respiration > 35 beats/min, or the patient requests to stop during exercise.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date March 1, 2022
Est. primary completion date March 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. Aged over 20 years old 2. Conscious 3. willing to participate in this study, and signed the consent form 4. no lower extremity activity taboo, and can walk independently before admission Exclusion Criteria: 1. Have neuromuscular disease. 2. Unable to step on a bed bike.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
exercise bike
exercise is to use an exercise bike, start pedaling on the first day, time setting: 20 minutes, speed: 2, and adopt passive mode. If you can complete the exercise on the first day, the time will be adjusted to 30 minutes on the second day. If you cannot complete the exercise on the first day, the time will still start from 20 minutes on the second day. The maximum time is 30 minutes. If you can complete 30 minutes of passive exercise for 3 consecutive days, the fourth day will be adjusted to active exercise. The entire exercise training is seven days a week, once a day, once a 30-minute, at least 5 days. Those who were discharged to the general ward continued to complete this exercise training for up to 28 days.

Locations

Country Name City State
Taiwan TaipeiVGH Taipei Taipei City, Taiwan

Sponsors (1)

Lead Sponsor Collaborator
Taipei Veterans General Hospital, Taiwan

Country where clinical trial is conducted

Taiwan, 

References & Publications (8)

Ali NA, O'Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JC, Almoosa K, Hejal R, Wolf KM, Lemeshow S, Connors AF Jr, Marsh CB; Midwest Critical Care Consortium. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J — View Citation

Camargo Pires-Neto R, Fogaça Kawaguchi YM, Sayuri Hirota A, Fu C, Tanaka C, Caruso P, Park M, Ribeiro Carvalho CR. Very early passive cycling exercise in mechanically ventilated critically ill patients: physiological and safety aspects--a case series. PLo — View Citation

De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation. Paresis acquired in the int — View Citation

Eggmann S, Verra ML, Luder G, Takala J, Jakob SM. Effects of early, combined endurance and resistance training in mechanically ventilated, critically ill patients: A randomised controlled trial. PLoS One. 2018 Nov 14;13(11):e0207428. doi: 10.1371/journal. — View Citation

Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, Casaer MP, Meersseman P, Debaveye Y, Van Cromphaut S, Wouters PJ, Gosselink R, Van den Berghe G. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A c — View Citation

Kho ME, Molloy AJ, Clarke FJ, Ajami D, McCaughan M, Obrovac K, Murphy C, Camposilvan L, Herridge MS, Koo KK, Rudkowski J, Seely AJ, Zanni JM, Mourtzakis M, Piraino T, Cook DJ; Canadian Critical Care Trials Group. TryCYCLE: A Prospective Study of the Safet — View Citation

Kho ME, Molloy AJ, Clarke FJ, Reid JC, Herridge MS, Karachi T, Rochwerg B, Fox-Robichaud AE, Seely AJ, Mathur S, Lo V, Burns KE, Ball IM, Pellizzari JR, Tarride JE, Rudkowski JC, Koo K, Heels-Ansdell D, Cook DJ. Multicentre pilot randomised clinical trial — View Citation

Machado ADS, Pires-Neto RC, Carvalho MTX, Soares JC, Cardoso DM, Albuquerque IM. Effects that passive cycling exercise have on muscle strength, duration of mechanical ventilation, and length of hospital stay in critically ill patients: a randomized clinic — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Basic Demographic Health Assessment Form Age, sex, diagnosis, disease severity, reason for ICU admission baseline
Primary days in intensive care unit Health Assessment Form baseline
Primary days on ventilator Health Assessment Form baseline
Primary total days in hospital Health Assessment Form baseline
Primary body mass index Health Assessment Form baseline
Primary level of albumin Health Assessment Form baseline
Primary The daily observation record sheet includes Vital signs,respirator is used or not,bicycle use pattern,speed and time,reasons for stopping up to 28 days
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength baseline(T0)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 3 days after intervention(T1)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 7 days after intervention(T2)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 10 days after intervention(T3)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 14 days after intervention(T4)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 17 days after intervention(T5)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 21 days after intervention(T6)
Secondary Hand grip strength Using a Grip Strength Tester to Measure Dominant Hand Muscle Strength 28 days after intervention(T7)
Secondary foot lift Use a tape to measure foot lift baseline(T0)
Secondary foot lift Use a tape to measure foot lift 3 days after intervention(T1)
Secondary foot lift Use a tape to measure foot lift 7days after intervention(T2)
Secondary foot lift Use a tape to measure foot lift 10days after intervention(T3)
Secondary foot lift Use a tape to measure foot lift 14days after intervention(T4)
Secondary foot lift Use a tape to measure foot lift 17ays after intervention(T5)
Secondary foot lift Use a tape to measure foot lift 21days after intervention(T6)
Secondary foot lift Use a tape to measure foot lift 28days after intervention(T7)
Secondary walking distance in 6 minutes Measure 6-minute walking distance baseline(T0)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 3 days after intervention(T1)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 7 days after intervention(T2)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 10days after intervention(T3)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 14days after intervention(T4)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 17days after intervention(T5)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 21days after intervention(T6)
Secondary walking distance in 6 minutes Measure 6-minute walking distance 28ays after intervention(T7)
See also
  Status Clinical Trial Phase
Recruiting NCT04081987 - Evaluation and Calibration of a Novel Non-invasive Wearable Device for Monitoring Vital Signs
Not yet recruiting NCT06416540 - Upper Extremity Theraband Exercises in Intensive Care Patients N/A
Completed NCT01907347 - Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients N/A
Completed NCT02292134 - Improving Sleep Quality in ICU Patients Phase 3
Completed NCT04502771 - Therapeutic Drug Monitoring of Antifungals in Intensive Care Units